-
-
-
-
-
-
-
FibroGen (FGEN) Misses Q2 EPS by $1.79
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on FibroGen (FGEN)
-
-
-
-
-
-
-
FibroGen (FGEN) PT Lowered to $0.60 at Goldman Sachs
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

